United States Asthma Drugs Market 2015-2019 - Rise in Disease Prevalence with AstraZeneca, F. Hoffmann-La Roche, GlaxoSmithKline & Merck Dominating

The analysts forecast the asthma drugs market in the US to grow at a CAGR of 4.64% over the period 2014-2019.

The report, Asthma Drugs Market in the US 2015-2019, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects in the coming years. The report also includes a discussion of the key vendors operating in this market.

Patients with persistent asthma symptoms are treated with drugs for both symptomatic relief and as a preventive measure. This helps in the reduction of asthma flare-ups. Generally, a patient is prescribed LABA or leukotriene receptor antagonist (LTRA) along with ICS. LABA and LTRA differ in their mechanisms of action but both provide complementary benefits in combination with an ICS. They help to manage asthma by improving lung function, reducing symptoms, providing bronchoprotection, and controlling the underlying inflammation.

According to the report, pharmaceutical companies are developing drugs that have a better safety and efficacy profile than those already available in the market. These drugs are undergoing clinical trials or are awaiting approval by regulatory agencies. For instance, NVA237 by Novartis and Mepolizumab by GlaxoSmithKline are among the most promising drugs for the treatment of asthma. Mepolizumab by GlaxoSmithKline was submitted for approval as a maintenance treatment for severe eosinophilic asthma to the US Food and Drug Administration (FDA) in November 2014. Tralokinumab by AstraZeneca is another promising molecule, which is under phase III clinical trials.

Further, the report states that the unknown etiology of the condition makes it difficult for pharmaceutical companies to develop a curative drug for the treatment of asthma.

To calculate the market size, the report considers the revenue generated from the sale of various classes of drugs used to treat asthma, which include:

Key vendors

Key Topics Covered:

For more information visit http://www.researchandmarkets.com/research/7pwczx/asthma_drugs

Media Contact: Laura Wood , +353-1-481-1716, [email protected]